First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
Post the sale, Patel family has become the single largest promoter shareholder in the company
UHI is envisioned as a foundational layer of the Ayushman Bharat Digital Mission and aims to enable interoperability in health services in India through open protocols
LG Chem will receive totaling up to $95.5 million for the China rights
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
The hospital is being developed at a cost of more than Rs. 1,575 crore
Company to open new headquarters in 2024
Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib – as well as KEYTRUDA (pembrolizumab) in multiple blood cancers
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
Subscribe To Our Newsletter & Stay Updated
